Enhanced implant-to-implant communications using accelerometer

ABSTRACT

Embodiments described herein relate to implantable medical devices (IMDs) and methods for use therewith. Such a method includes using an accelerometer of an IMD (e.g., a leadless pacemaker) to produce one or more accelerometer outputs indicative of the orientation of the IMD. The method can also include controlling communication pulse parameter(s) of one or more communication pulses (produced by pulse generator(s)) based on accelerator output(s) indicative of the orientation of the IMD. The communication pulse parameter(s) that is/are controlled can be, e.g., communication pulse amplitude, communication pulse width, communication pulse timing, and/or communication pulse morphology. Such embodiments can be used to improve conductive communications between IMDs whose orientation relative to one another may change over time, e.g., due to changes in posture and/or due to cardiac motion over a cardiac cycle.

PRIORITY CLAIM

This application claims priority to U.S. Provisional Patent ApplicationNo. 62/731,317, filed Sep. 14, 2018, which is incorporated herein byreference.

FIELD OF TECHNOLOGY

Embodiments described herein generally relate to methods and systems forcommunication between implantable medical devices, such as, but notlimited to, leadless pacemakers.

BACKGROUND

Some medical systems rely on wireless communication between multipleimplantable medical devices (IMDs). For example, in certain cardiacpacing systems, multiple IMDs wirelessly communicate with one another toreliably and safely coordinate pacing and/or sensing operations. Such asystem may include, for example, one or more leadless pacemakers (LPs),an implantable cardioverter-defibrillator (ICD), such as asubcutaneous-ICD, and/or a programmer. For a more specific example,certain such systems include an LP in the right ventricle (RV) andanother LP in the right atrium (RA), wherein the LPs in the RV and RAwirelessly communicate with one another to coordinate pacing and/orsensing operations. Such wireless communication between two IMDs (e.g.,two LPs) is often referred to as implant-to-implant (i2i) communication.

When using a pair of LPs to perform pacing and/or sensing operations inthe RA and RV, one of the challenges is that i2i communication is reliedupon to maintain appropriate synchrony between the RA and the RV.However, it has been observed that such i2i communication can beadversely affected by the orientation of the LPs relative to oneanother.

SUMMARY

Embodiments of the present technology relate to implantable medicaldevices (IMDs) and methods for use therewith. A method according to anembodiment of the present is for use with an IMD that includes one ormore pulse generators and an accelerometer. The accelerometer isconfigured to selectively produce one or more accelerometer outputsindicative of an orientation of the IMD. The one or more pulsegenerators is/are configured to selectively produce stimulation pulsesand communication pulses. Such stimulation pulses are for use in pacinga cardiac chamber or performing neuromodulation. Such communicationpulses are for use in performing conductive communication with anotherIMD or a non-implanted device.

In accordance with certain embodiments, the method includes using theaccelerometer to produce one or more accelerometer outputs indicative ofthe orientation of the IMD. The method also includes controlling atleast one communication pulse parameter of one or more communicationpulses produced by at least one of the one or more pulse generators,wherein the controlling is based on at least one of the one or moreaccelerator outputs indicative of the orientation of the IMD. The atleast one communication pulse parameter, that is controlled based on atleast one of the one or more accelerator outputs indicative of theorientation of the IMD, can comprise, e.g., communication pulseamplitude, communication pulse width, communication pulse timing, and/orcommunication pulse morphology.

In accordance with certain embodiments, the IMD comprises a leadlesspacemaker (LP) configured to be implanted in a cardiac chamber. Incertain such embodiments the one or more accelerometer outputs is/areindicative of the orientation of the LP, the stimulation pulses are foruse in pacing the cardiac chamber within which the LP is implanted, andthe one or more communication pulses are for use in performingconductive communication with another LP. For example, one of the LPscan be implanted in the right atrium (RA), while the other LP isimplanted in the right ventricle (RV), thereby enabling biventricularpacing to be performed. The one or more accelerometer outputs can beused to determine, e.g., the orientation of the LP relative to gravity,the orientation of the LP relative to an orientation of the other LP,and/or a posture of a patient within which the LP is implanted.

In accordance with certain embodiments, at least one communication pulseparameter is controlled, based on at least one of the one or moreaccelerator outputs indicative of the orientation of the LP, so that oneor more communication pulses having a specified communication pulseamplitude is/are temporally produced so that a sense amplitude of one ormore communication pulses received by the other LP will exceed a sensethreshold. Additionally, at least one communication pulse parameter canbe controlled, based on at least one of the one or more acceleratoroutputs indicative of the orientation of the LP, so that one or morecommunication pulses is/are temporally produced during a refractoryperiod of the cardiac chamber within which the LP is implanted.

Additionally, or alternatively, at least one communication pulseparameter is controlled, based on at least one of the one or moreaccelerator outputs indicative of the orientation of the LP, so that asense amplitude of one or more communication pulses received by theother LP will exceed a sense threshold. This can include, e.g.,increasing at least one of the communication pulse amplitude or thecommunication pulse width in response to predicting that without theincreasing one or more communication pulses received by the other LPwill be below a sense threshold. In accordance with certain embodiments,in order to conserve power, at least one of the communication pulseamplitude or the communication pulse width is reduced in response topredicting that even with the reducing communication pulses received bythe other LP will exceed a sense threshold.

Each of the LPs can include a plurality of electrodes that can be usedfor transmitting and receiving communication pulses. In accordance withcertain embodiments, one of the LPs controls, based on at least one ofthe one or more accelerator outputs indicative of the orientation of theone of the LPs, which electrodes, of the plurality of electrodes of oneof the LPs, are used to transmit or receive communication pulses to orfrom the other one of the LPs.

An IMD, according to certain embodiments of the present technology,includes one or more pulse generators, an accelerometer, and acontroller. The accelerometer is configured to selectively produce oneor more accelerometer outputs indicative of an orientation of the IMD.The controller, which is communicatively coupled to the accelerometerand to the one or more pulse generators, is configured to control atleast one communication pulse parameter of one or more communicationpulses produced by at least one of the one or more pulse generators,based on at least one of the one or more accelerator outputs indicativeof the orientation of the IMD. The at least one communication pulseparameter, that the controller controls (based on at least one of theone or more accelerator outputs indicative of the orientation of theIMD) can comprise, e.g., communication pulse amplitude, communicationpulse width, communication pulse timing, and/or communication pulsemorphology.

An implantable system, according to an embodiment of the presenttechnology, includes a first LP implanted within an atrial chamber, anda second LP implanted within a ventricular chamber. Each of the firstand second LPs including one or more pulse generators configured toselectively produce stimulation pulses and communication pulses, thestimulation pulses for use in pacing the cardiac chamber within whichthe LP is implanted, and the communication pulses for use in performingconductive communication with the other LP. The first LP includes anaccelerometer configured to selectively produce one or moreaccelerometer outputs indicative of an orientation of the first LP. Thefirst LP also including a controller communicatively coupled to theaccelerometer and to the one or more pulse generators of the first LP.The controller of the first LP is configured to control at least onecommunication pulse parameter of one or more communication pulsesproduced by at least one of the one or more pulse generators of thefirst LP, based on at least one of the one or more accelerator outputsindicative of the orientation of the first LP. Similarly, the second LPcan include an accelerometer configured to selectively produce one ormore accelerometer outputs indicative of an orientation of the secondLP. The second LP can further include a controller communicativelycoupled to the accelerometer and to the one or more pulse generators ofthe second LP. The controller of the second LP can be configured tocontrol at least one communication pulse parameter (examples of whichwere mentioned above) of one or more communication pulses produced by atleast one of the one or more pulse generators of the second LP, based onat least one of the one or more accelerator outputs indicative of theorientation of the second LP.

This summary is not intended to be a complete description of theembodiments of the present technology. Other features and advantages ofthe embodiments of the present technology will appear from the followingdescription in which the preferred embodiments have been set forth indetail, in conjunction with the accompanying drawings and claims.

BRIEF DESCRIPTION OF THE DRAWINGS

Embodiments of the present technology relating to both structure andmethod of operation may best be understood by referring to the followingdescription and accompanying drawings, in which similar referencecharacters denote similar elements throughout the several views:

FIG. 1A illustrates a system formed in accordance with certainembodiments described herein as implanted in a heart.

FIG. 1B is a block diagram of a single leadless pacemaker (LP) inaccordance with certain embodiments herein.

FIG. 2 illustrates an LP in accordance with certain embodiments herein.

FIG. 3 is a timing diagram demonstrating one embodiment of implant toimplant (i2i) communication for a paced event.

FIG. 4 is a timing diagram demonstrating one embodiment of i2icommunication for a sensed event.

FIG. 5 is a diagram that is used to show how the orientation of twodifferent LPs can be quantified in accordance with certain embodimentsof the present technology.

FIG. 6 is used to illustrates how an LP and/or external programmer canconvert local coordinate system measurements to global coordinatemeasurements in accordance with certain embodiments of the presenttechnology.

FIG. 7 includes a diagram and equations that illustrate one exemplarymanner in which a local coordinate system can be converted to a globalcoordinate system.

FIGS. 8A and 8B are a high level flow diagrams that are used tosummarize methods according to various embodiments of the presenttechnology that can be used to improve or otherwise control conductivecommunications.

FIG. 9 shows a block diagram of one embodiment of an LP that isimplanted into a patient as part of an implantable cardiac system inaccordance with certain embodiments herein.

DETAILED DESCRIPTION

Certain embodiments of the present technology relate to implantablesystems, and methods for use therewith, that use one or more outputs ofan accelerometer to improve conductive communications between multipleimplantable medical device (IMDs) or between a non-implantableprogrammer and an IMD.

Before providing addition details of the specific embodiments of thepresent technology mentioned above, an exemplary system in whichembodiments of the present technology can be used will first bedescribed with reference to FIGS. 1A, 1B and 2. More specifically, FIGS.1A, 1B and 2 will be used to describe an exemplary cardiac pacingsystem, wherein pacing and sensing operations can be performed bymultiple medical devices, which may include one or more leadlesspacemakers (LPs), an implantable cardioverter-defibrillator (ICD), suchas a subcutaneous-ICD, and/or a programmer reliably and safelycoordinate pacing and/or sensing operations.

FIG. 1A illustrates a system 100 formed in accordance with certainembodiments herein as implanted in a heart 101. The system 100 comprisestwo or more leadless pacemakers (LPs) 102 and 104 located in differentchambers of the heart. LP 102 is located in a right atrium (RA), whileLP 104 is located in a right ventricle (RV). The RA is also known as theright atrial chamber, and the RV is also known as the right ventricularchamber. LPs 102 and 104 communicate with one another to inform oneanother of various local physiologic activities, such as local intrinsicevents, local paced events and the like. LPs 102 and 104 may beconstructed in a similar manner, but operate differently based uponwhich chamber LP 102 or 104 is located.

In some embodiments, LPs 102 and 104 communicate with one another, withan ICD 106, and with an external device (programmer) 109 throughwireless transceivers, communication coils and antenna, and/or byconductive communication through the same electrodes as used for sensingand/or delivery of pacing therapy. When conductive communication ismaintained through the same electrodes as used for pacing, the system100 may omit an antenna or telemetry coil in one or more of LPs 102 and104.

In some embodiments, one or more LPs 102 and 104 can be co-implantedwith the implantable cardioverter-defibrillator (ICD) 106. Each LP 102,104 uses two or more electrodes located within, on, or within a fewcentimeters of the housing of the LP, for pacing and sensing at thecardiac chamber, for bidirectional communication with one another, withthe programmer 109, and the ICD 106.

In accordance with certain embodiments, methods are provided forcoordinating operation between LPs located in different chambers of theheart. The methods can configure a local LP to receive communicationsfrom a remote LP through conductive communication. While the methods andsystems described herein include examples primarily in the context ofLPs, it is understood that the methods and systems herein may beutilized with various other external and implanted devices. By way ofexample, the methods and systems may coordinate operation betweenvarious other types implantable medical devices (IMDs) implanted in ahuman, not just LPs.

Referring to FIG. 1B, a block diagram shows exemplary electronics withinLPs 102 and 104. LP 102, 104 includes first and second receivers 120 and122 that collectively define separate first and second communicationchannels 105 and 107 (FIG. 1A), (among other things) between LPs 102 and104. Although first and second receivers 120 and 122 are depicted, inother embodiments, LP 102, 104 may only include first receiver 120, ormay include additional receivers other than first and second receivers120 and 122. As will be described in additional detail below, the pulsegenerator 116 can function as a transmitter that transmitsimplant-to-implant (i2i) communication signals using the electrodes 108.Usage of the electrodes 108 for communication enables the one or moreLPs 102 and 104 to perform antenna-less and telemetry coil-lesscommunication.

In accordance with certain embodiments, when one of the LPs 102 and 104senses an intrinsic event or delivers a paced event, the correspondingLP 102, 104 transmits an implant event message to the other LP 102, 104.For example, when an atrial LP 102 senses/paces an atrial event, theatrial LP 102 transmits an implant event message including an eventmarker indicative of a nature of the event (e.g., intrinsic/sensedatrial event, paced atrial event). When a ventricular LP 104senses/paces a ventricular event, the ventricular LP 104 transmits animplant event message including an event marker indicative of a natureof the event (e.g., intrinsic/sensed ventricular event, pacedventricular event). In certain embodiments, LP 102, 104 transmits animplant event message to the other LP 102, 104 preceding the actual pacepulse so that the remote LP can blank its sense inputs in anticipationof that remote pace pulse (to prevent inappropriate crosstalk sensing).

Still referring to FIG. 1B, each LP 102, 104 is shown as including acontroller 112 and a pulse generator 116. The controller 112 caninclude, e.g., a microprocessor (or equivalent control circuitry), RAMand/or ROM memory, logic and timing circuitry, state machine circuitry,and I/O circuitry, but is not limited thereto. The controller 112 canfurther include, e.g., timing control circuitry to control the timing ofthe stimulation pulses (e.g., pacing rate, atrio-ventricular (AV) delay,atrial interconduction (A-A) delay, or ventricular interconduction (V-V)delay, etc.). Such timing control circuitry may also be used for thetiming of refractory periods, blanking intervals, noise detectionwindows, evoked response windows, alert intervals, marker channeltiming, and so on. The controller 112 can further include otherdedicated circuitry and/or firmware/software components that assist inmonitoring various conditions of the patient's heart and managing pacingtherapies. The controller 112 and the pulse generator 116 may beconfigured to transmit event messages, via the electrodes 108, in amanner that does not inadvertently capture the heart in the chamberwhere LP 102, 104 is located, such as when the associated chamber is notin a refractory state. In addition, a LP 102, 104 that receives an eventmessage may enter an “event refractory” state (or event blanking state)following receipt of the event message. The event refractory/blankingstate may be set to extend for a determined period of time after receiptof an event message in order to avoid the receiving LP 102, 104 frominadvertently sensing another signal as an event message that mightotherwise cause retriggering. For example, the receiving LP 102, 104 maydetect a measurement pulse from another LP 102, 104 or programmer 109.

In accordance with certain embodiments herein, the programmer 109 maycommunicate over a programmer-to-LP channel, with LP 102, 104 utilizingthe same communication scheme. The external programmer 109 may listen tothe event message transmitted between LP 102, 104 and synchronizeprogrammer to implant communication such that programmer 109 does nottransmit communication signals 113 until after an implant to implantmessaging sequence is completed.

In accordance with certain embodiments, LP 102, 104 may combine transmitoperations with therapy. The transmit event marker may be configured tohave similar characteristics in amplitude and pulse-width to a pacingpulse and LP 102, 104 may use the energy in the event messages to helpcapture the heart. For example, a pacing pulse may normally be deliveredwith pacing parameters of 2.5V amplitude, 500 ohm impedance, 60 bpmpacing rate, 0.4 ms pulse-width. The foregoing pacing parameterscorrespond to a current draw of about 1.9 μA. The same LP 102, 104 mayimplement an event message utilizing event signaling parameters foramplitude, pulse-width, pulse rate, etc. that correspond to a currentdraw of approximately 0.5 μA for transmit.

LP 102, 104 may combine the event message transmissions with pacingpulses. For example, LP 102, 104 may use a 50 μs wakeup transmit pulsehaving an amplitude of 2.5V which would draw 250 nC (nano Coulombs) foran electrode load of 500 ohm. The pulses of the transmit event messagemay be followed by an event message encoded with a sequence of shortduration pulses (for example 16, 2 μs on/off bits) which would draw anadditional 80 nC. The event message pulse would then be followed by theremaining pulse-width needed to reach an equivalent charge of a nominal0.4 ms pace pulse. In this case, the current necessary to transmit themarker is essentially free as it was used to achieve the necessary pacecapture anyhow. With this method, the savings in transmit current couldbe budgeted for the receiver or would allow for additional longevity.

When LP 102 or 104 senses an intrinsic event, it can send aqualitatively similar event pulse sequence (but indicative of a sensedevent) without adding the pace pulse remainder. As LP 102, 104 longevitycalculations are designed based on the assumption that LP 102, 104 willdeliver pacing therapy 100% of the time, transmitting an intrinsic eventmarker to another LP 102, 104 will not impact the nominal calculated LPlongevity.

In some embodiments, the individual LP 102 can comprise a hermetichousing 110 configured for placement on or attachment to the inside oroutside of a cardiac chamber and at least two leadless electrodes 108proximal to the housing 110 and configured for bidirectionalcommunication with at least one other device 106 within or outside thebody.

Referring to FIG. 1B, the LP 102 (or 104) is shown as including anaccelerometer 154 which can be hermetically contained within the housing110. The accelerometer 154 can be any one of various different types ofwell known accelerometers, or can be a future developed accelerometer.For one example, the accelerometer 154 can be or include, e.g., a MEMS(micro-electromechanical system) multi-axis accelerometer of the typeexploiting capacitive or optical cantilever beam techniques, or apiezoelectric accelerometer that employs the piezoelectric effect ofcertain materials to measure dynamic changes in mechanical variables.Where the accelerometer is a multi-axis accelerometer it can include twoor three sensors aligned along orthogonal axes. Exemplary multi-axisaccelerometers (also referred to as multi-dimensional accelerometers)that can be used are described in U.S. Pat. No. 6,658,292 (Kroll et al.)and U.S. Pat. No. 6,466,821 (Pianca et al.), each of which isincorporated herein by reference. For another example, a commerciallyavailable micro-electromechanical system (MEMS) accelerometer marketedas the ADXL345 by Analog Devices, Inc. (headquartered in Norwood, Mass.)is a three-axis accelerometer and includes polysilicon springs thatprovide a resistance against acceleration forces. The term MEMS has beendefined generally as a system or device having micro-circuitry on a tinysilicon chip into which some mechanical device such as a mirror or asensor has been manufactured. The aforementioned ADXL345 includes amicro-machined accelerometer co-packaged with a signal processing IC.

Another commercially available MEMS accelerometer is the ADXL327 byAnalog Devices, Inc., which is a small, thin, low power, complete threeaxis accelerometer with signal conditioned voltage outputs. In theADXL327, the mechanical sensor and signal conditioning IC are packagedtogether. A further commercially available MEMS accelerometer that canbe used is the LIS3DH three-axis accelerometer by STMicroelectronics(headquartered in Geneva, Switzerland). Additional and/or alternativetypes of accelerometers may also be used. For example, it is also withinthe scope of the present technology for the accelerometer 154 to be abeam-type of accelerometer, an example of which is described in U.S.Pat. No. 6,252,335 (Nilsson et al.), which is incorporated herein byreference.

The accelerometer 154 can be, e.g., a one-dimensional (1D) accelerometer(also known as a one-axis accelerometer), a two-dimensional (2D)accelerometer (also known as a two-axis accelerometer), or athree-dimensional (3D) accelerometer (also known as a three-axisaccelerometer). A 1D accelerometer measures acceleration along one axis,e.g., the z-axis. A 2D accelerometer measures acceleration along twoaxes that are orthogonal to one another, e.g., the z-axis, and the x- ory-axis. A 3D accelerometer measures acceleration along three axes thatare orthogonal to one another, e.g., the z-axis, the x-axis, and they-axis. Each measure of acceleration (i.e., rate of change of velocity)can actually be a measure of proper acceleration, which is the rate ofchange of velocity of a body in its own instantaneous rest frame. Forexample, an accelerometer at rest on the surface of the Earth willmeasure an acceleration due to Earth's gravity, straight upwards (bydefinition) of g 9.81 m/s{circumflex over ( )}2.

Where an IMD (e.g., LP 102 or 104) includes an accelerometer within ahousing of the IMD or attached thereto, the accelerometer can be used tomeasure the acceleration of the IMD along one or more axes, whichmeasurement(s) can be used to determine the orientation of the IMD.Accordingly, because the output(s) of the accelerometer can be used todetermine the orientation of the IMD, it can be said that the output(s)of the accelerometer (e.g., 154) are indicative of an orientation of theIMD (e.g., LP 102 or 104). More specifically, in accordance with certainembodiments, the controller 112 of an LP 102 (or 104) receives one ormore outputs output(s) of the accelerometer 154, which is/are indicativeof an orientation of the LP 102 (or 104). In such embodiments, thecontroller 112 can determine, based on the output(s) received from theaccelerometer 154, an actual orientation of the LP 102 (or 104). Eachoutput of the accelerometer 154 can comprise a respective signal.

One or more signals produced and output by the accelerometer 154 may beanalyzed with respect to frequency content, energy, duration, amplitudeand/or other characteristics. Such signals may or may not be amplifiedand/or filtered prior to being analyzed. For example, filtering may beperformed using lowpass, highpass and/or bandpass filters. The signalsoutput by the accelerometer 154 can be analog signals, which can beanalyzed in the analog domain, or can be converted to digital signals(by an analog-to-digital converter) and analyzed in the digital domain.Alternatively, the signals output by the accelerometer 154 can alreadybe in the digital domain.

The one or more signals output by the accelerometer 154 can be analyzedby the controller 112 and/or other circuitry. In certain embodiments,the accelerometer 154 is packaged along with an integrated circuit (IC)that is designed to analyze the signal(s) it generates. In suchembodiments, one or more outputs of the packaged sensor/IC can be anindication of acceleration along one or more axes. In other embodiments,the accelerometer 154 can be packaged along with an IC that performssignal conditioning (e.g., amplification and/or filtering), performsanalog-to-digital conversions, and stores digital data (indicative ofthe sensor output) in memory (e.g., RAM, which may or may not be withinthe same package). In such embodiments, the controller 112 or othercircuitry can read the digital data from the memory and analyze thedigital data. Other variations are also possible, and within the scopeof embodiments of the present technology.

FIG. 1B depicts a single LP 102 (or 104) and shows the LP's functionalelements substantially enclosed in a hermetic housing 110. The LP 102(or 104) has at least two electrodes 108 located within, on, or near thehousing 110, for delivering pacing pulses to and sensing electricalactivity from the muscle of the cardiac chamber, for sensing motion, forsensing temperature, and for bidirectional communication with at leastone other device within or outside the body. Hermetic feedthroughs 130,131 conduct electrode signals through the housing 110. The housing 110contains a primary battery 114 to supply power for pacing, sensing, andcommunication. The housing 110 also contains circuits 132 for sensingcardiac activity from the electrodes 108, receivers 120, 122 forreceiving information from at least one other device via the electrodes108, and the pulse generator 116 for generating pacing pulses fordelivery via the electrodes 108 and also for transmitting information toat least one other device via the electrodes 108. The housing 110 canfurther contain circuits for monitoring device health, for example abattery current monitor 136 and a battery voltage monitor 138, and cancontain circuits for controlling operations in a predetermined manner.

The electrodes 108 can be configured to communicate bidirectionallyamong the multiple LPs and/or the implanted ICD 106 to coordinate pacingpulse delivery and optionally other therapeutic or diagnostic featuresusing messages that identify an event at an individual LP originatingthe message and an LP receiving the message react as directed by themessage depending on the origin of the message. An LP 102, 104 thatreceives the event message reacts as directed by the event messagedepending on the message origin or location. In some embodiments orconditions, the two or more leadless electrodes 108 can be configured tocommunicate bidirectionally among the one or more LPs 102, 104 and/orthe ICD 106 and transmit data including designated codes for eventsdetected or created by an individual LP. Individual LPs can beconfigured to issue a unique code corresponding to an event type and alocation of the sending pacemaker.

In some embodiments, an individual LP 102, 104 can be configured todeliver a pacing pulse with an event message encoded therein, with acode assigned according to pacemaker location and configured to transmita message to one or more other LPs via the event message coded pacingpulse. The pacemaker or pacemakers receiving the message are adapted torespond to the message in a predetermined manner depending on type andlocation of the event.

Moreover, information communicated on the incoming channel can alsoinclude an event message from another leadless cardiac pacemakersignifying that the other leadless cardiac pacemaker has sensed aheartbeat or has delivered a pacing pulse, and identifies the locationof the other pacemaker. For example, LP 104 may receive and relay anevent message from LP 102 to the programmer. Similarly, informationcommunicated on the outgoing channel can also include a message toanother LP, or to the ICD, that the sending leadless cardiac pacemakerhas sensed a heartbeat or has delivered a pacing pulse at the locationof the sending pacemaker.

Referring again to FIGS. 1 and 2, the cardiac pacing system 100 maycomprise an implantable cardioverter-defibrillator (ICD) 106 in additionto LPs 102, 104 configured for implantation in electrical contact with acardiac chamber and for performing cardiac rhythm management functionsin combination with the implantable ICD 106. The implantable ICD 106 andthe one or more LPs 102, 104 can be configured for leadlessintercommunication by information conduction through body tissue and/orwireless transmission between transmitters and receivers in accordancewith the discussed herein. As mentioned above, the ICD 106 can includeits own motion sensor and/or temperature sensor.

As shown in the illustrative embodiments, an LP 102, 104 can comprisetwo or more leadless electrodes 108 configured for delivering cardiacpacing pulses, sensing evoked and/or natural cardiac electrical signals,and bidirectionally communicating with the co-implanted ICD 106.

LP 102, 104 can be configured for operation in a particular location anda particular functionality at manufacture and/or at programming by anexternal programmer 109. Bidirectional communication among the multipleleadless cardiac pacemakers can be arranged to communicate notificationof a sensed heartbeat or delivered pacing pulse event and encoding typeand location of the event to another implanted pacemaker or pacemakers.LP 102, 104 receiving the communication decode the information andrespond depending on location of the receiving pacemaker andpredetermined system functionality.

In some embodiments, the LPs 102 and 104 are configured to beimplantable in any chamber of the heart, namely either atrium (RA, LA)or either ventricle (RV, LV). Furthermore, for dual-chamberconfigurations, multiple LPs may be co-implanted (e.g., one in the RAand one in the RV, or one in the RV and one in the coronary sinusproximate the LV). Certain pacemaker parameters and functions depend on(or assume) knowledge of the chamber in which the pacemaker is implanted(and thus with which the LP is interacting; e.g., pacing and/orsensing). Some non-limiting examples include: sensing sensitivity, anevoked response algorithm, use of AF suppression in a local chamber,blanking and refractory periods, etc. Accordingly, each LP preferablyknows an identity of the chamber in which the LP is implanted, andprocesses may be implemented to automatically identify a local chamberassociated with each LP.

Processes for chamber identification may also be applied to subcutaneouspacemakers, ICDs, with leads and the like. A device with one or moreimplanted leads, identification and/or confirmation of the chamber intowhich the lead was implanted could be useful in several pertinentscenarios. For example, for a DR or CRT device, automatic identificationand confirmation could mitigate against the possibility of the clinicianinadvertently placing the V lead into the A port of the implantablemedical device, and vice-versa. As another example, for an SR device,automatic identification of implanted chamber could enable the deviceand/or programmer to select and present the proper subset of pacingmodes (e.g., AAI or VVI), and for the IPG to utilize the proper set ofsettings and algorithms (e.g., V-AutoCapture vs. ACap-Confirm, sensingsensitivities, etc.).

Also shown in FIG. 1B, the primary battery 114 has positive terminal 140and negative terminal 142. Current from the positive terminal 140 ofprimary battery 114 flows through a shunt 144 to a regulator circuit 146to create a positive voltage supply 148 suitable for powering theremaining circuitry of the pacemaker 102. The shunt 144 enables thebattery current monitor 136 to provide the controller 112 with anindication of battery current drain and indirectly of device health. Theillustrative power supply can be a primary battery 114.

In various embodiments, LP 102, 104 can manage power consumption to drawlimited power from the battery, thereby reducing device volume. Eachcircuit in the system can be designed to avoid large peak currents. Forexample, cardiac pacing can be achieved by discharging a tank capacitor(not shown) across the pacing electrodes. Recharging of the tankcapacitor is typically controlled by a charge pump circuit. In aparticular embodiment, the charge pump circuit is throttled to rechargethe tank capacitor at constant power from the battery.

In some embodiments, the controller 112 in one LP 102, 104 can accesssignals on the electrodes 108 and can examine output pulse duration fromanother pacemaker for usage as a signature for determining triggeringinformation validity and, for a signature arriving within predeterminedlimits, activating delivery of a pacing pulse following a predetermineddelay of zero or more milliseconds. The predetermined delay can bepreset at manufacture, programmed via an external programmer, ordetermined by adaptive monitoring to facilitate recognition of thetriggering signal and discriminating the triggering signal from noise.In some embodiments or in some conditions, the controller 112 canexamine output pulse waveform from another leadless cardiac pacemakerfor usage as a signature for determining triggering information validityand, for a signature arriving within predetermined limits, activatingdelivery of a pacing pulse following a predetermined delay of zero ormore milliseconds.

In certain embodiments, the electrodes of an LP 102, 104 can be used tosense an intracardiac electrocardiogram (IEGM) from which atrial and/orventricular activity can be detected, e.g., by detecting QRS complexesand/or P waves. Such an IEGM can also be used by an LP 102, 104 to timewhen communication pulses should be generated, since the orientation ofthe LPs 102, 104 relative to one another can change throughout eachcardiac cycle.

FIG. 2 shows an LP 102, 104. The LP can include a hermetic housing 202(e.g., the housing 110 in FIG. 1) with electrodes 108 a and 108 bdisposed thereon. As shown, electrode 108 a can be separated from butsurrounded partially by a fixation mechanism 205, and the electrode 108b can be disposed on the housing 202. The fixation mechanism 205 can bea fixation helix, a plurality of hooks, barbs, or other attachingfeatures configured to attach the pacemaker to tissue, such as hearttissue. The electrodes 108 a and 108 b are examples of the electrodes108 shown in and discussed above with reference to FIG. 1B. One of theelectrodes 108 (e.g., 108 a) can function as a cathode type electrodeand another one of the electrodes 108 (e.g., 108 b) can function as ananode type electrode, or vice versa, when the electrodes are used fordelivering stimulation.

The housing 202 can also include an electronics compartment 210 withinthe housing that contains the electronic components necessary foroperation of the pacemaker, including, e.g., a pulse generator,receiver, a battery, and a processor for operation. The hermetic housing202 can be adapted to be implanted on or in a human heart, and can becylindrically shaped, rectangular, spherical, or any other appropriateshapes, for example.

The housing 202 can comprise a conductive, biocompatible, inert, andanodically safe material such as titanium, 316L stainless steel, orother similar materials. The housing 202 can further comprise aninsulator disposed on the conductive material to separate electrodes 108a and 108 b. The insulator can be an insulative coating on a portion ofthe housing between the electrodes, and can comprise materials such assilicone, polyurethane, parylene, or another biocompatible electricalinsulator commonly used for implantable medical devices. In theembodiment of FIG. 2, a single insulator 208 is disposed along theportion of the housing between electrodes 108 a and 108 b. In someembodiments, the housing itself can comprise an insulator instead of aconductor, such as an alumina ceramic or other similar materials, andthe electrodes can be disposed upon the housing.

As shown in FIG. 2, the pacemaker can further include a header assembly212 to isolate 108 a and 108 b. The header assembly 212 can be made fromPEEK, tecothane or another biocompatible plastic, and can contain aceramic to metal feedthrough, a glass to metal feedthrough, or otherappropriate feedthrough insulator as known in the art.

The electrodes 108 a and 108 b can comprise pace/sense electrodes, orreturn electrodes. A low-polarization coating can be applied to theelectrodes, such as sintered platinum, platinum-iridium, iridium,iridium-oxide, titanium-nitride, carbon, or other materials commonlyused to reduce polarization effects, for example. In FIG. 2, electrode108 a can be a pace/sense electrode and electrode 108 b can be a returnelectrode. The electrode 108 b can be a portion of the conductivehousing 202 that does not include an insulator 208.

Several techniques and structures can be used for attaching the housing202 to the interior or exterior wall of the heart. A helical fixationmechanism 205, can enable insertion of the device endocardially orepicardially through a guiding catheter. A torqueable catheter can beused to rotate the housing and force the fixation device into hearttissue, thus affixing the fixation device (and also the electrode 108 ain FIG. 2) into contact with stimulable tissue. Electrode 108 b canserve as an indifferent electrode for sensing and pacing. The fixationmechanism may be coated partially or in full for electrical insulation,and a steroid-eluting matrix may be included on or near the device tominimize fibrotic reaction, as is known in conventional pacingelectrode-leads.

Implant-to-Implant Event Messaging

LPs 102 and 104 can utilize implant-to-implant (i2i) communicationthrough event messages to coordinate operation with one another invarious manners. The terms i2i communication, i2i event messages, andi2i even markers are used interchangeably herein to refer to eventrelated messages and IMD/IMD operation related messages transmitted froman implanted device and directed to another implanted device (althoughexternal devices, e.g., a programmer, may also receive i2i eventmessages). In certain embodiments, LP 102 and LP 104 operate as twoindependent leadless pacers maintaining beat-to-beat dual-chamberfunctionality via a “Master/Slave” operational configuration. Fordescriptive purposes, the ventricular LP 104 shall be referred to as“vLP” and the atrial LP 102 shall be referred to as “aLP”. LP 102, 104that is designated as the master device (e.g. vLP) may implement all ormost dual-chamber diagnostic and therapy determination algorithms. Forpurposes of the following illustration, it is assumed that the vLP is a“master” device, while the aLP is a “slave” device. Alternatively, theaLP may be designated as the master device, while the vLP may bedesignated as the slave device. The master device orchestrates most orall decision-making and timing determinations (including, for example,rate-response changes).

In accordance with certain embodiments, methods are provided forcoordinating operation between first and second leadless pacemakers(LPs) configured to be implanted entirely within first and secondchambers of the heart. A method transmits an event marker throughconductive communication through electrodes located along a housing ofthe first LP, the event marker indicative of one of a local paced orsensed event. The method detects, over a sensing channel, the eventmarker at the second LP. The method identifies the event marker at thesecond LP based on a predetermined pattern configured to indicate thatan event of interest has occurred in a remote chamber. In response tothe identifying operation, the method initiates a related action in thesecond LP.

FIG. 3 is a timing diagram 300 demonstrating one example of an i2icommunication for a paced event. The i2i communication may betransmitted, for example, from LP 102 to LP 104. As shown in FIG. 3, inthis embodiment, an i2i transmission 302 is sent prior to delivery of apace pulse 304 by the transmitting LP (e.g., LP 102). This enables thereceiving LP (e.g., LP 104) to prepare for the remote delivery of thepace pulse. The i2i transmission 302 includes an envelope 306 that mayinclude one or more individual pulses. For example, in this embodiment,envelope 306 includes a low frequency pulse 308 followed by a highfrequency pulse train 310. Low frequency pulse 308 lasts for a periodT_(i2iLF), and high frequency pulse train 310 lasts for a periodT_(i2iHF). The end of low frequency pulse 308 and the beginning of highfrequency pulse train 310 are separated by a gap period, T_(i2iGap).

As shown in FIG. 3, the i2i transmission 302 lasts for a period Ti2iP,and pace pulse 304 lasts for a period Tpace. The end of i2i transmission302 and the beginning of pace pulse 304 are separated by a delay period,TdelayP. The delay period may be, for example, between approximately 0.0and 10.0 milliseconds (ms), particularly between approximately 0.1 msand 2.0 ms, and more particularly approximately 1.0 ms. The termapproximately, as used herein, means+/−10% of a specified value.

FIG. 4 is a timing diagram 400 demonstrating one example of an i2icommunication for a sensed event. The i2i communication may betransmitted, for example, from LP 102 to LP 104. As shown in FIG. 4, inthis embodiment, the transmitting LP (e.g., LP 102) detects the sensedevent when a sensed intrinsic activation 402 crosses a sense threshold404. A predetermined delay period, T_(delayS), after the detection, thetransmitting LP transmits an i2i transmission 406 that lasts apredetermined period T_(i2iS). The delay period may be, for example,between approximately 0.0 and 10.0 milliseconds (ms), particularlybetween approximately 0.1 ms and 2.0 ms, and more particularlyapproximately 1.0 ms.

As with i2i transmission 302, i2i transmission 406 may include anenvelope that may include one or more individual pulses. For example,similar to envelope 406, the envelope of i2i transmission 406 mayinclude a low frequency pulse followed by a high frequency pulse train.

Optionally, wherein the first LP is located in an atrium and the secondLP is located in a ventricle, the first LP produces an AS/AP eventmarker to indicate that an atrial sensed (AS) event or atrial paced (AP)event has occurred or will occur in the immediate future. For example,the AS and AP event markers may be transmitted following thecorresponding AS or AP event. Alternatively, the first LP may transmitthe AP event marker slightly prior to delivering an atrial pacing pulse.Alternatively, wherein the first LP is located in an atrium and thesecond LP is located in a ventricle, the second LP initiates anatrioventricular (AV) interval after receiving an AS or AP event markerfrom the first LP; and initiates a post atrial ventricular blanking(PAVB) interval after receiving an AP event marker from the first LP.

Optionally, the first and second LPs may operate in a “pure”master/slave relation, where the master LP delivers “command” markers inaddition to or in place of “event” markers. A command marker directs theslave LP to perform an action such as to deliver a pacing pulse and thelike. For example, when a slave LP is located in an atrium and a masterLP is located in a ventricle, in a pure master/slave relation, the slaveLP delivers an immediate pacing pulse to the atrium when receiving an APcommand marker from the master LP.

In accordance with some embodiments, communication and synchronizationbetween the aLP and vLP is implemented via conducted communication ofmarkers/commands in the event messages (per i2i communication protocol).As explained above, conducted communication represents event messagestransmitted from the sensing/pacing electrodes at frequencies outsidethe RF or Wi-Fi frequency range. Alternatively, the event messages maybe conveyed over communication channels operating in the RF or Wi-Fifrequency range. The figures and corresponding description belowillustrate non-limiting examples of markers that may be transmitted inevent messages. The figures and corresponding description below alsoinclude the description of the markers and examples of results thatoccur in the LP that receives the event message. Table 1 representsexemplary event markers sent from the aLP to the vLP, while Table 2represents exemplary event markers sent from the vLP to the aLP. In themaster/slave configuration, AS event markers are sent from the aLP eachtime that an atrial event is sensed outside of the post ventricularatrial blanking (PVAB) interval or some other alternatively-definedatrial blanking period. The AP event markers are sent from the aLP eachtime that the aLP delivers a pacing pulse in the atrium. The aLP mayrestrict transmission of AS markers, whereby the aLP transmits AS eventmarkers when atrial events are sensed both outside of the PVAB intervaland outside the post ventricular atrial refractory period (PVARP) orsome other alternatively-defined atrial refractory period.Alternatively, the aLP may not restrict transmission of AS event markersbased on the PVARP, but instead transmit the AS event marker every timean atrial event is sensed.

TABLE 1 “A2V” Markers/Commands (i.e., from aLP to vLP) MarkerDescription Result in vLP AS Notification of a sensed event Initiate AVinterval (if not in in atrium (if not in PVAB or PVAB or PVARP) PVARP)AP Notification of a paced event in Initiate PAVB atrium Initiate AVinterval (if not in PVARP)

As shown in Table 1, when an aLP transmits an event message thatincludes an AS event marker (indicating that the aLP sensed an intrinsicatrial event), the vLP initiates an AV interval timer. If the aLPtransmits an AS event marker for all sensed events, then the vLP wouldpreferably first determine that a PVAB or PVARP interval is not activebefore initiating an AV interval timer. If however the aLP transmits anAS event marker only when an intrinsic signal is sensed outside of aPVAB or PVARP interval, then the vLP could initiate the AV intervaltimer upon receiving an AS event marker without first checking the PVABor PVARP status. When the aLP transmits an AP event marker (indicatingthat the aLP delivered or is about to deliver a pace pulse to theatrium), the vLP initiates a PVAB timer and an AV interval time,provided that a PVARP interval is not active. The vLP may also blank itssense amplifiers to prevent possible crosstalk sensing of the remotepace pulse delivered by the aLP.

TABLE 2 “V2A” Markers/Commands (i.e., from vLP to aLP) MarkerDescription Result in aLP VS Notification of a sensed event InitiatePVARP in ventricle VP Notification of a paced event in Initiate PVABventricle Initiate PVARP AP Command to deliver immediate Deliverimmediate pace pace pulse in atrium pulse to atrium

As shown in Table 2, when the vLP senses a ventricular event, the vLPtransmits an event message including a VS event marker, in response towhich the aLP may initiate a PVARP interval timer. When the vLP deliversor is about to deliver a pace pulse in the ventricle, the vLP transmitsVP event marker. When the aLP receives the VP event marker, the aLPinitiates the PVAB interval timer and also the PVARP interval timer. TheaLP may also blank its sense amplifiers to prevent possible crosstalksensing of the remote pace pulse delivered by the vLP. The vLP may alsotransmit an event message containing an AP command marker to command theaLP to deliver an immediate pacing pulse in the atrium upon receipt ofthe command without delay.

The foregoing event markers are examples of a subset of markers that maybe used to enable the aLP and vLP to maintain full dual chamberfunctionality. In one embodiment, the vLP may perform all dual-chamberalgorithms, while the aLP may perform atrial-based hardware-relatedfunctions, such as PVAB, implemented locally within the aLP. In thisembodiment, the aLP is effectively treated as a remote ‘wireless’ atrialpace/sense electrode. In another embodiment, the vLP may perform mostbut not all dual-chamber algorithms, while the aLP may perform a subsetof diagnostic and therapeutic algorithms. In an alternative embodiment,vLP and aLP may equally perform diagnostic and therapeutic algorithms.In certain embodiments, decision responsibilities may be partitionedseparately to one of the aLP or vLP. In other embodiments, decisionresponsibilities may involve joint inputs and responsibilities.

In an embodiment, ventricular-based pace and sense functionalities arenot dependent on any i2i communication, in order to provide safertherapy. For example, in the event that LP to LP (i2i) communication islost (prolonged or transient), the system 100 may automatically revertto safe ventricular-based pace/sense functionalities as the vLP deviceis running all of the necessary algorithms to independently achievethese functionalities. For example, the vLP may revert to a VVI mode asthe vLP does not depend on i2i communication to perform ventricularpace/sense activities. Once i2i communication is restored, the system100 can automatically resume dual-chamber functionalities.

Enhanced i2i Communication Using Accelerometer

As noted above, when using a pair of LPs (e.g., 102, 104) to performpacing and/or sensing operations in the RA and RV, one of the challengesis that i2i communication is relied upon to maintain appropriatesynchrony between the RV and the RA.

As also noted above, a transmitter (e.g., 118) of an LP 102, 104 may beconfigured to transmit event messages in a manner that does notinadvertently capture the heart in the chamber where LP 102, 104 islocated, such as when the associated chamber is not in a refractorystate. In addition, an LP 102, 104 that receives an event message mayenter an “event refractory” state (or event blanking state) followingreceipt of the event message. The event refractory/blanking state may beset to extend for a determined period of time after receipt of an eventmessage in order to avoid the receiving LP 102, 104 from inadvertentlysensing another signal as an event message that might otherwise causeretriggering. For example, the receiving LP 102, 104 may detect ameasurement pulse from another LP 102, 104. The amplitude of a detected(i.e., sensed) measurement pulse can be referred to as the sensedamplitude.

As noted above, it has been observed that i2i communication can beadversely affected by the orientation of the LPs relative to oneanother. Both computer simulations and animal testing have showed thatsensed amplitude varied widely with different orientation angles. Forexample, where a first LP (e.g., 102) transmits a pulse having a pulseamplitude of 2.5V to a second LP (e.g., 104), the sensed amplitude ofthe pulse received by the second LP (e.g., 104) could vary from about 2mV to less than 0.5 mV, depending upon the orientation between the firstand second LPs (e.g., 102 and 104). For example, where the LP 102 isimplanted in the right atrium (RA), and the LP 104 is implanted in theleft atrium (LA), e.g., as shown in FIG. 1A, the orientation of the LPs102 and 104 relative to one another can change over the course of eachcardiac cycle. Additionally, the orientation of the LPs 102 and 104relative to one another can be affected by the posture of the patient.Accordingly, since the sensed amplitude of a pulse received by one LP(e.g., 104) from the other LP (e.g., 102) can significantly vary basedon the orientation of the LPs relative to one another, the senseamplitude can significantly vary depending upon the timing of when apulse is transmitted during a cardiac cycle, as well as the posture ofthe patient when the pulse is transmitted.

Assume, for example, that an LP 102, 104 has a 0.5 mV sense threshold,meaning that a sensed pulse must have an amplitude of at least 0.5 mV inorder to be detected as a communication pulse by the receiving LP. Inother words, if sensed amplitudes of received communication pulses arebelow the sense threshold, the receiving LP will fail to receive theinformation encoded therein and may fail to respond accordingly, whichis undesirable.

FIG. 5 is a diagram that is used to show how the orientation of twodifferent LPs (e.g., 102, 104), labeled LP2 and LP1 in FIG. 5, can bequantified. Referring to FIG. 5, the LP2 (e.g., 102) is shown as havingan axis 502, and the LP1 (e.g., 104) is shown as having an axis 504. Theline D12 represents the distance between the LP1 and the LP2. In FIG. 5,the angle α12 is the angle between the axis 504 of the LP1 and the lineD12; the angle β12 is the angle between the axis 502 of the LP2 and theline D12; and the angle γ12 is angle between the plane defined by theangle α12 and the plane defined by the angle β12.

Table 3, below, provides the results of simulations that show how sensedamplitudes are affected by the orientation of LP1 and LP2 relative toone another, where the LP2 is assumed to be implanted in the RA, the LP1is assumed to be implanted in the RV, and the distance D12 is assumed tobe fixed at 125 millimeters (mm).

TABLE 3 Distance Angle Angle D12 α12 β12 RA → RV RA ← RV 124 mm 20° 12°2.5 V → 2.13 mV 2.11 mV ←2.5 V 124 mm 20° 32° 2.5 V → 1.82 mV N/A 124 mm20° 52° 2.5 V → 1.32 mV N/A 124 mm 20° 72° 2.5 V → 0.745 mV N/A 124 mm20° 82° 2.5 V → 0.470 mV 0.460 mV ←2.5 V 124 mm 20° 92° 2.5 V → 0.198 mV0.198 mV ←2.5 V 124 mm 10° 82° 2.5 V → N/A 0.6627 mV 124 mm 40° 82° 2.5V → N/A −0.1135 mV 124 mm 50° 82° N/A N/A

The first row of Table 3 shows that when the angle β12 (i.e., the anglebetween the axis 502 of the LP2 and the line D12) is 12 degrees, inresponse to the LP2 transmitting a communication pulse having anamplitude of 2.5V, the sense amplitude of the communication pulsereceived by the LP1 will be 2.13 mV, which is well above a 0.5 mV sensethreshold. By contrast, the sixth row of Table 3 shows that when theangle β12 is 92 degrees, in response to the LP2 transmitting acommunication pulse having an amplitude of 2.5V, the sense amplitude ofthe communication pulse received by the LP1 will be only 0.198 mV, whichis well below the 0.5 mV sense threshold. Looking at the right mostcolumn and the first row of Table 3 shows that when the angle β12 is 12degrees, in response to the LP1 transmitting a communication pulsehaving an amplitude of 2.5V, the sense amplitude of the communicationpulse received by the LP2 will be 2.11 mV, which is well above a 0.5 mVsense threshold; and when the angle β12 is 92 degrees, in response tothe LP1 transmitting a communication pulse having an amplitude of 2.5V,the sense amplitude of the communication pulse received by the LP2 willbe only 0.198 mV, which is well below the 0.5 mV sense threshold.

With larger heart sizes, the sensed amplitudes decrease. Morespecifically, a larger heart can cause the distance D12 between the LP1and the LP2 to increase, with the results summarized in Table 4, below.

TABLE 4 Distance D12 Angle α12 Angle β12 RA → RV RA ← RV 150 mm 20° 12°2.5 V → 0.96 mV N/A 150 mm 20° 32° 2.5 V → 0.76 mV N/A 150 mm 20° 52°2.5 V → 0.51 mV N/A 150 mm 20° 72° 2.5 V → 0.25 mV N/A 150 mm 20° 82°2.5 V → 0.12 mV N/A 150 mm 20° 92° 2.5 V → 0.005 mV N/A 150 mm 20° 52°2.5 V → 0.51 mV N/A 150 mm 10° 52° 2.5 V → 0.59 mV N/A 150 mm 40° 52°2.5 V → 0.27 mV N/A

The results summarized in Table 4 mimic a worst case where the heartsize is at the upper bounds (D12˜150 mm). As can be appreciated from acomparison between Table 4 and Table 3, the sensed amplitudes decreasedas D12 was increased from 124 mm to 150 mm, so that in Table 4 when theangle β12 is greater than 52 degree, the sensed amplitude is lower thanthe 0.5 mV sense threshold. Accordingly, it can be appreciated that i2icommunications between LPs implanted in larger hearts are even moreadversely affected than smaller hearts by the relative orientation ofthe LPs.

When performing i2i communication, the one or more pulses that aretransmitted from one LP to another LP can be referred more generally asthe i2i signal. Due to the nature of electrode potential distribution,bipolar sensing of the i2i signal (by the LP that is receiving/sensingthe i2i signal) is minimal along iso-potential lines and maximum alonglines orthogonal to the iso-potential lines. In other words, when therespective axes (e.g., 502 and 504 in FIG. 5) of the two LPs(communicating with one another) are aligned with one another the sensedi2i signal is near its maximum, and when the respective axes (e.g., 502and 504 in FIG. 5) of the two LPs are orthogonal to one another thesensed i2i signal is near its minimum.

For the purpose of this discussion, when LPs are oriented relative toanother such that (for a give transmitted communication pulse amplitude)the sense amplitude of the communication pulse received by an LP will bebelow the sense threshold (e.g., 0.5 mV), the LPs can be said to bewithin a “deaf zone”. This is because under such circumstances the LPscannot successfully communicate or “hear” one another even though theyare attempting to communicate or “talk” with one another.

Certain embodiments of the present technology utilize one or moreaccelerometers to time the sending and/or receiving of communicationpulses during time windows when the LPs (or other types of IMDs) are notwithin a deaf zone, or more generally, when the LPs (or other types ofIMDs) have an acceptable alignment or orientation. In other words, inaccordance with certain embodiments, communication pulse timing iscontrolled based on one or more accelerator outputs. Alternatively, oradditionally, one or more accelerometers can be used to control one ormore other types of communication pulse parameters besides communicationpulse timing. For example, in accordance with certain embodiments,communication pulse amplitude and/or width may be increased when LPs (orother types of IMDs) are within or close to a deaf zone to improve thechance that a sense amplitude exceeds a sense threshold. Additionally,or alternatively, it would also be possible to modify a communicationpulse morphology based on one or more accelerometer outputs. Forexample, a decision to transmit either biphasic or monophasiccommunication pulses can depend upon one or more accelerometer outputs.For example, in accordance with certain embodiments, communication pulsemorphology can be changed from a first morphology (e.g., monophasic) toa second morphology (e.g., biphasic) when LPs (or other types of IMDs)are within or close to a deaf zone to improve the chance that a senseamplitude exceeds a sense threshold. Further, in certain embodimentscommunication pulse amplitude and/or width may be decreased when it isdetermined that LPs (or other types of IMDs) are oriented relative toone another such that sense amplitudes will be at or close to maximum(e.g., when respective axes of two LPs are aligned or close to aligned).More generally, in accordance with certain embodiments of the presenttechnology, at least one communication pulse parameter of one or morecommunication pulses (produced by at least one of one or more pulsegenerators, e.g., 116 in FIG. 2B) is/are controlled based on one or moreoutputs of one or more accelerometers (e.g., 154 in FIG. 2B).

Within this description, phrases such as “the orientation of two LPs (orother type of IMDs) relative to one another” are used synonymously withphrases such as “the orientation of one LP (or other type of IMD)relative to another LP (or other IMD)”. In accordance with certainembodiments of the present technology, the orientation of two LPs (orother type of IMDs) relative to one another is taken into account tocontrol at least one communication pulse parameter (e.g., pulseamplitude, pulse width, pulse timing, and/or pulse morphology) in orderto improve the probability that communication from one of the LPs (orother type of IMD) to the other is successful, and more specifically,exceeds a sense threshold.

One possible way that an LP (or other type of IMD) can determine whetherit is at an acceptable orientation relative to another LP (or other typeof IMD) is by receiving orientation information from the other LP.However, this would not practical where the whole purpose of a first LPobtaining the orientation information from a second LP is to determinewhether and/or how the first LP should communicate with the second LP.To overcome this problem, in accordance with certain embodiments of thepresent technology, an initialization process is performed which, atlater times, enables a first LP (or other type of IMD) to determine alikely orientation relative to a second LP (or other type of IMD) basedon the first LP's own orientation, a posture of a patient within whichthe LPs are implanted, and/or cardiac cycle timing.

In accordance with certain embodiments, an initialization process cantake place (e.g., in a physician's or clinician's office) while the twoLPs (or other types of IMDs) are in communication with an externalprogrammer, at the same time, or one after the other. Alternatively,each of the LPs (or other types of IMDs) can go through aninitialization routine, save its results, and upload the saved resultsto an external program (e.g., 109 in FIG. 1A).

During an initialization period, for each of a plurality of differentpostures (e.g., supine, sitting, and standing, but not limited thereto),accelerometer data can be obtained for each LP, and such data can beused to determine the relative orientation of two LPs over the course ofa cardiac cycle for each of the plurality of different postures. Basedon such accelerometer data, a respective table can be generated for eachLP (or other type of IMD) by the external programmer and then downloadedto the LPs (or other types of IMDs). Such tables enable each individualLP to determine a likely orientation of the other LP based on its ownorientation (or more generally, its own acceleration output(s)), aposture of the patient (as determined based on its own accelerationoutput(s)), and/or timing within a cardiac cycle (as determined based onan IEGM obtained using electrodes of the LP). The timing within acardiac cycle is likely important because the orientation of an LP canvary over each cardiac cycle, e.g., as the cardiac chamber within which(or to which) the LP is attached expands and contracts. Based on such atable, an LP can determine when it is acceptable to send one or morecommunication pulses to another LP at a baseline communication pulseamplitude and width. Additionally, or alternatively, the LP candetermine when it should delay sending the communication pulse(s),and/or increase the communication pulse amplitude and/or width, and/ormodify the communication pulse morphology, in order to increase aprobability that when the communication pulse(s) is/are received by theother LP the sense threshold is exceeded (thereby enabling the other LPto successfully receive and interpret the communication pulse(s)).

In accordance with certain embodiments, the orientation of each LP (orother type of IMD) can be determined within a global coordinate systemdefined by or relative to gravity. For example, each LP can determineits own orientation based on three outputs of its own 3D accelerometer,and such measures can be translated into the global coordinate systemdefined by or relative to gravity. This way multiple LPs (or other typesof IMDs) can utilize a common coordinate system, i.e., the globalcoordinate system. For a more specific example, each LP can determineits own values of θ and φ, based on outputs of its respectiveaccelerometer and using a calibration process, and such values can beused to derive values for the angles α12 and β12, discussed above withreference to FIG. 5 and Tables 3 and 4. Such a calibration process maybe performed, e.g., during one or more office visits, during which aglobal z axis can be determined while a patient is standing, a global xaxis can extend from arm to arm of the patient, and a global y axiswould be orthogonal to the global z and x axes. With the global axesdefined, values of θ and φ can be determined. The diagram and equationsshown in FIG. 7 illustrate one exemplary way that a local coordinatesystem can be converted to a global coordinate system. In the presentcase, the variable r=gravity g, and the solid angle dΩ can be used todefine each posture associated with the local coordinate angles θ and φ.Other variations are possible and within the embodiments of the presenttechnology described herein.

Where the accelerometer 154 of an LP (or other type of IMD) is a 3Daccelerometer, the accelerometer can produce three outputs, one of whichis indicative of acceleration in the x-direction, one of which isindicative of acceleration in the y-direction, and one of which isindicative of acceleration in the z-direction. Each of these threeoutputs can be, e.g., a DC signal having a magnitude that isproportional to acceleration in a specific direction. It is alsopossible that each of these three outputs can be a digital valueindicative of acceleration in a specific direction. Regardless of theformat of the outputs, the outputs can correspond to a local coordinatesystem of the IMD within which the accelerometer is located. Forexample, the three outputs of the accelerometer of the LP1 can bereferred to as x1, y1, and z1; and the three outputs of theaccelerometer of the LP2 can be referred to as x2, y2, and z2. Inaccordance with certain embodiments, gravity g can be used as a globalreference that enables a determination of the orientation of LP1 and LP2relative to one another. For example, this can be accomplished bymathematically projecting gravity g to the 3D accelerometer outputsproduced by LP1 to produce gx1, gy1, gz1, and by LP2 to produce gx2,gy2, gz2.

Depending upon implementation, e.g., including the specific tablesstored in the LPs, an LP can determine whether it (and/or another LP) islikely in a deaf zone based on outputs of its own accelerometer (e.g.,154) as well as cardiac cycle timing as determined based on an IEGMobtaining using its own electrodes (e.g., 108). As already noted above,an LP has a few options when it determines that it (and/or another LP)is likely in a deaf zone. The LP can increase its communication pulseamplitude and/or communication pulse width. Alternatively, oradditionally, the LP can delay sending one or more communicationpulse(s) until it (and/or the other LP) is no longer within a deaf zone.In accordance with certain embodiments, the amount of the delay, whichcan be referred to as the delta (Δ), should be less than an absoluterefractory period (˜200 ms). Additionally, where communication pulse(s)is/are being sent from an LP within an atrium (e.g., the RA) to an LPwithin a ventricle (e.g., the RV), the amount of the delay (i.e., Δ)should also be less than a programmed AV delay, especially when thecommunication pulse(s) is/are being used to inform the LP within the RVof a sensed or paced event in the RA.

In certain embodiments, if a first LP predicts (based on its ownorientation and the likely orientation of a second LP) that pulses thefirst LP sends to the second LP (using a baseline amplitude and pulsewidth) will be received below, but close, to the sense threshold (e.g.,will be slightly less than 0.5 mV), then the first LP can determine thatit should increase its pulse amplitude and/or pulse width when sendingcommunication pulse(s) to the second LP. However, if the first LPpredicts that pulses it sends to the second LP will be receivedsignificantly below the sense threshold (e.g., will be much less than0.5 mV), then the first LP can decide to delay sending the pulses untilthe relative orientation of the LPs is more acceptable.

In accordance with certain embodiments, whenever a first LP delayssending communication pulse(s) to a second LP, the first LP informs thesecond LP of the amount of communication delay. That way the second LPwill known if it needs to adjust certain timed events based on thecommunication delay. For an example, assume a first LP located in the RAsends communication pulses to a second LP in order to inform the secondLP of a sensed or paced even in the RA. Also assume that the second LPis programmed to pace the RV at in accordance with predetermined AVdelay of 220 ms. If the first LP send communication pulses to the secondLP immediately upon pacing or sensing an atrial even, then the second LPcan simply trigger delivery of the RV pacing 220 ms (i.e., the AV delay)after receiving the communication pulses from the first LP (potentiallyminus some time it is presumed for the communication to occur). However,if the first LP didn't send its communication pulses to the second LPuntil some delay (e.g., 50 ms) after pacing or sensing an atrial even,then the second LP would need to know of and compensate for such adelay, e.g., by triggering delivery of the RV pacing based on the AVdelay minus the communication delay (and potentially minus some time itis presumed for the communication to occur). In accordance with certainembodiments, certain bits of a communication packet sent from the firstLP to the second LP can be designated for specifying such acommunication delay. Other variations are also possible and within thescope of embodiments of the present technology described herein.

A potential problem with an LP relying on its accelerometer to determineits orientation is that the LP will be unable to determine itsorientation when it is orthogonal to gravity (g). When an LP (e.g., LP1)determines from its accelerometer that it is orthogonal to gravity (g),then that LP (e.g., LP1) cannot determine its own orientation, and thus,cannot determine (e.g., from a table and/or algorithm) the orientationof another LP (e.g., LP2) with which the LP (e.g., LP1) wants tocommunicate. Thus, when an LP determines that it is orthogonal togravity, that LP cannot determine whether itself and/or another LP islikely in a deaf zone. To overcome this problem, the LP can wait untilit is no longer orthogonal to gravity (e.g., because its own orientationchanged due to cardiac motion) to determine its own orientation and/orthe orientation of another LP. This is another example of when an LP maydelay sending one or more communication pulse(s) to another LP. Once theLP is no longer orthogonal to gravity, and can determine its ownorientation, the LP can also determine the orientation of another LP, ina manner described above, to know if it should further delay sendingcommunication pulse(s) and/or adjust the amplitude of communicationpulse(s).

As noted above, in certain embodiments, one LP may act as a “master”device, while another LP acts as a “slave” device. For example, asexplained above, where there are two LPs, with one in an atrium and theother in a ventricle, the vLP can act as the “master” device, while theaLP acts as the “slave” device. In certain such embodiments, the slaveLP can send its accelerometer data (alone, or together with other data,such as atrial activity data) to the master LP via conductive i2icommunications, and the master LP can use its own accelerometer data andthe accelerometer data received from the slave LP to calculate θ and φfor both LPs to determine when they may be in or close to the “deafzone”. More generally, in certain embodiments a master LP can determinethe orientation of itself based on its own accelerometer data anddetermine the orientation of the slave LP based on accelerometer datareceived from the slave LP. This should work fine so long as the slaveLP does not try to send its accelerometer data to the master LP viaconductive i2i communications when the master LP is in the deaf zone.One way to overcome this potential problem is for the slave LP to keepresending its accelerometer data (alone, or together with other data,such as atrial activity data) via conductive i2i communications to themaster LP until the slave LP receives a reception acknowledgement backfrom the master LP. The resent i2i communication pulses can be sent at adelay after to the initial i2i communications pulses, to try to takeadvantage of the likelihood that the orientation of the LPs relative toone another may have changed (e.g., due to cardiac motion), and thus,that they are no longer in the deaf zone. Additionally, oralternatively, the resent i2i communication pulses can be sent at anincreased amplitude, increasing the probability that when received atthe master LP they will exceed the sense threshold. If accelerometerdata is resent along with other data, such as atrial activity data, at adelayed time relative to when it was initially sent, the slave LP caninform the master LP of the time delay so that the master LP candetermine, e.g., an actual time of atrial activity, or the like.

While in many examples described above, the communication pulses weredescribed as being used for performing conductive communications betweenLPs, embodiments of the present technology can also be used to improveconductive communications between other types of IMDs (besides LPs), aswell as to improve conductive communications between an IMD (e.g., an LPor ICD) and a non-implanted device (e.g., an external programmer).Further, while in many examples described above the IMDs (e.g., LPs orICD) were described as being used to deliver cardiac stimulation (e.g.,for pacing or defibrillation), it is also possible that one or more ofthe IMDs be used to deliver neurostimulation, such as, but not limitedto, spinal cord stimulation (SCS), dorsal root ganglion (DRG)stimulation, brain stimulation, deep brain stimulation, and/or the like.In other words, IMDs that implement embodiments of the presenttechnology can alternatively be (or include) a neurostimulator that,similar to an LP or ICD, also included one or more pulse generators thatproduce stimulation pulses and communication pulses.

The high level flow diagram of FIG. 8A will be now be used to summarizemethods for use with an IMD that includes one or more pulse generatorsand an accelerometer, wherein the accelerometer is configured toselectively produce one or more accelerometer outputs indicative of anorientation of the IMD, and the one or more pulse generators is/areconfigured to selectively produce stimulation pulses and communicationpulses. The stimulation pulses can be used for pacing a cardiac chamber.The stimulation pulses can alternatively be used for performingneuromodulation. The communication pulses are for use in performingconductive communication with another IMD or a non-implanted device.

Referring to FIG. 8A, step 802 involves using the accelerometer toproduce one or more accelerometer outputs indicative of the orientationof the IMD. Referring briefly back to FIG. 1B, step 802 can beperformed, e.g., using the accelerometer 154 under the control of thecontroller 112.

Referring again to FIG. 8A, step 804 involves controlling at least onecommunication pulse parameter of one or more communication pulsesproduced by at least one of the one or more pulse generators, whereinthe controlling is based on at least one of the one or more acceleratoroutputs indicative of the orientation of the IMD. Referring briefly backto FIG. 1B again, step 804 can be performed, e.g., using the controller112 and the pulse generator 116.

The communication pulse parameter(s), that is/are controlled at step 804(based on at least one of the one or more accelerator outputs indicativeof the orientation of the IMD) can be one or more of communication pulseamplitude, communication pulse width, communication pulse timing, orcommunication pulse morphology.

As can be appreciated from the above discussion of FIGS. 1-7, in certainembodiments, the IMD with which the methods summarized with reference toFIG. 8A can be used, can be an LP (e.g., 102 and/or 104) configured tobe implanted in a cardiac chamber, e.g., the RA or RV. In suchembodiments, the accelerometer output(s) can be indicative of theorientation of the LP, and more specifically, can be indicative of theorientation of the LP relative to gravity, indicative of the orientationof the LP relative to an orientation of the other LP, and/or indicativeof a posture of a patient within which the LP is implanted.Additionally, in such embodiments, the stimulation pulses can be for usein pacing the cardiac chamber within which the LP is implanted, and thecommunication pulses can be for use in performing conductivecommunication with another LP. As can be appreciated from the abovediscussion of FIGS. 1A, 1B and 2, such an LP can include electrodes(e.g., 108) that can be used for transmitting and receivingcommunication pulses, as well as for sensing and delivering cardiacstimulation.

In accordance with certain embodiments, step 804 involves controllingthe communication pulse timing so that one or more communication pulseshaving a specified communication pulse amplitude is/are temporallyproduced so that a sense amplitude of one or more communication pulsesreceived by the other LP will exceed a sense threshold (e.g., 0.5 mV).

In accordance with certain embodiments, step 804 involves controllingthe communication pulse timing so that one or more communication pulsesis/are temporally produced during a refractory period of the cardiacchamber within which the LP is implanted.

In accordance with certain embodiments, step 804 involves controllingthe communication pulse amplitude and/or the communication pulse widthso that a sense amplitude of one or more communication pulses receivedby the other LP will exceed a sense threshold. For example, this caninclude increasing the communication pulse amplitude and/or thecommunication pulse width in response to predicting that without suchincreasing communication pulses received by the other LP will be belowthe sense threshold.

In accordance with certain embodiments, step 804 involves reducing thecommunication pulse amplitude and/or the communication pulse width inresponse to predicting that even with the reducing communication pulsesreceived by the other LP will exceed a sense threshold. Such embodimentscan be used to conserve power, and thus, increase the longevity of theIMD that is implementing such a method.

In still other embodiments, accelerator output(s) can be used to guide,or at least help guide, an auto-adjusting of the sense threshold.Additionally, or alternatively, accelerator output(s) can be used to“steer” i2i communications in order to limit effects on nearby devicesnot intended to detect a particular communication.

The high level flow diagram of FIG. 8B will now be used to summarizefurther features of the embodiments described herein. Referring to FIG.8B, step 812 involves for each IMD (e.g., LP) performing aninitialization process in order to obtain accelerometer outputs fromeach IMD for each of a plurality of different postures and/or timeswithin a cardiac cycle.

Step 814 involves, for each IMD (e.g., LP), converting accelerometeroutputs from a local coordinate system of the IMD to a global coordinatesystem referenced to gravity g.

Step 816 involves, for each IMD (e.g., LP), generating a table that canbe used by the IMD to determine whether or not it is likely in a deafzone based on outputs of its own accelerometer as well as cardiac cycletiming as determined based on an IEGM obtaining using its ownelectrodes.

Step 818 involves, for each IMD (e.g., LP), storing within the IMD(e.g., in the IMD's memory) the table that has been generated for theIMD, so that the table can be used by the IMD to control communicationpulse parameter(s) of communication pulse(s) produced by pulsegenerator(s) of the IMD, based on accelerator output(s) produced by theaccelerometer of the IMD.

In the exemplary LP 102, 104 described above with reference to FIGS. 1A,1B and 2, the LP was shown as and described as having a pair ofelectrodes 108 (e.g., labeled 108 a and 108 b in FIG. 2). As wasmentioned above, one of the electrodes 108 (e.g., 108 a) can function asa cathode type electrode and another one of the electrodes 108 (e.g.,108 b) can function as an anode type electrode, or vice versa, when theelectrodes are used for delivering stimulation. In FIG. 2, the electrode108 b is shown as being a ring electrode that extends around an entirecircumference of a portion of the LP 102, 104. In alternativeembodiments, the electrode 108 b can be a slit ring electrode, meaningthe electrode 108 b can be capable of being electrically separated intohalves of some other portions (e.g., thirds, fourths, etc.), dependingupon design. For example, if split into halves, each half can take up180 degrees of a 360 degree ring; or if slit into quarters, each quartercan take up 90 degrees of a 360 degree ring. By changing which one ormore portion(s) of the electrode 108 b is/are used for sensing (ortransmitting) communication pulses, the sense vector (or transmissionvector) can be adjusted to improve conductive communication independence on the relative orientation of two LPs (or other types ofIMDs) as determined based on accelerometer outputs. More generally, inaccordance with certain embodiments, electrode sensing and/ortransmitting vectors can be adjusted based on one or more accelerometeroutputs to improve conductive communications.

FIG. 9 shows a block diagram of one embodiment of an LP 901 that isimplanted into the patient as part of the implantable cardiac system inaccordance with certain embodiments herein. LP 901 may be implemented asa full-function biventricular pacemaker, equipped with both atrial andventricular sensing and pacing circuitry for four chamber sensing andstimulation therapy (including both pacing and shock treatment).Optionally, LP 901 may provide full-function cardiac resynchronizationtherapy. Alternatively, LP 901 may be implemented with a reduced set offunctions and components. For instance, the IMD may be implementedwithout ventricular sensing and pacing.

LP 901 has a housing 900 to hold the electronic/computing components.Housing 900 (which is often referred to as the “can”, “case”,“encasing”, or “case electrode”) may be programmably selected to act asthe return electrode for certain stimulus modes. Housing 900 may furtherinclude a connector (not shown) with a plurality of terminals 902, 904,906, 908, and 910. The terminals may be connected to electrodes that arelocated in various locations on housing 900 or elsewhere within andabout the heart. LP 901 includes a programmable microcontroller 920 thatcontrols various operations of LP 901, including cardiac monitoring andstimulation therapy. Microcontroller 920 includes a microprocessor (orequivalent control circuitry), RAM and/or ROM memory, logic and timingcircuitry, state machine circuitry, and I/O circuitry.

LP 901 further includes a pulse generator 922 that generates stimulationpulses and communication pulses for delivery by one or more electrodescoupled thereto. Pulse generator 922 is controlled by microcontroller920 via control signal 924. Pulse generator 922 may be coupled to theselect electrode(s) via an electrode configuration switch 926, whichincludes multiple switches for connecting the desired electrodes to theappropriate I/O circuits, thereby facilitating electrodeprogrammability. Switch 926 is controlled by a control signal 928 frommicrocontroller 920.

In the embodiment of FIG. 9, a single pulse generator 922 isillustrated. Optionally, the IMD may include multiple pulse generators,similar to pulse generator 922, where each pulse generator is coupled toone or more electrodes and controlled by microcontroller 920 to deliverselect stimulus pulse(s) to the corresponding one or more electrodes.

Microcontroller 920 is illustrated as including timing control circuitry932 to control the timing of the stimulation pulses (e.g., pacing rate,atrio-ventricular (AV) delay, atrial interconduction (A-A) delay, orventricular interconduction (V-V) delay, etc.). Timing control circuitry932 may also be used for the timing of refractory periods, blankingintervals, noise detection windows, evoked response windows, alertintervals, marker channel timing, and so on. Microcontroller 920 alsohas an arrhythmia detector 934 for detecting arrhythmia conditions and amorphology detector 936. Although not shown, the microcontroller 920 mayfurther include other dedicated circuitry and/or firmware/softwarecomponents that assist in monitoring various conditions of the patient'sheart and managing pacing therapies. The microcontroller can include aprocessor. The microcontroller, and/or the processor thereof, can beused to perform the methods of the present technology described herein.

LP 901 is further equipped with a communication modem(modulator/demodulator) 940 to enable wireless communication with theremote slave pacing unit. Modem 940 may include one or more transmittersand two or more receivers as discussed herein in connection with FIG.1B. In one implementation, modem 940 may use low or high frequencymodulation. As one example, modem 940 may transmit i2i messages andother signals through conductive communication between a pair ofelectrodes. Modem 940 may be implemented in hardware as part ofmicrocontroller 920, or as software/firmware instructions programmedinto and executed by microcontroller 920. Alternatively, modem 940 mayreside separately from the microcontroller as a standalone component.

LP 901 includes a sensing circuit 944 selectively coupled to one or moreelectrodes, that perform sensing operations, through switch 926 todetect the presence of cardiac activity in the right chambers of theheart. Sensing circuit 944 may include dedicated sense amplifiers,multiplexed amplifiers, or shared amplifiers. It may further employ oneor more low power, precision amplifiers with programmable gain and/orautomatic gain control, bandpass filtering, and threshold detectioncircuit to selectively sense the cardiac signal of interest. Theautomatic gain control enables the unit to sense low amplitude signalcharacteristics of atrial fibrillation. Switch 926 determines thesensing polarity of the cardiac signal by selectively closing theappropriate switches. In this way, the clinician may program the sensingpolarity independent of the stimulation polarity.

The output of sensing circuit 944 is connected to microcontroller 920which, in turn, triggers or inhibits the pulse generator 922 in responseto the presence or absence of cardiac activity. Sensing circuit 944receives a control signal 946 from microcontroller 920 for purposes ofcontrolling the gain, threshold, polarization charge removal circuitry(not shown), and the timing of any blocking circuitry (not shown)coupled to the inputs of the sensing circuitry.

In the embodiment of FIG. 9, a single sensing circuit 944 isillustrated. Optionally, the IMD may include multiple sensing circuits,similar to sensing circuit 944, where each sensing circuit is coupled toone or more electrodes and controlled by microcontroller 920 to senseelectrical activity detected at the corresponding one or moreelectrodes. Sensing circuit 944 may operate in a unipolar sensingconfiguration or in a bipolar sensing configuration.

LP 901 further includes an analog-to-digital (ND) data acquisitionsystem (DAS) 950 coupled to one or more electrodes via switch 926 tosample cardiac signals across any pair of desired electrodes. Dataacquisition system 950 is configured to acquire intracardiac electrogramsignals, convert the raw analog data into digital data, and store thedigital data for later processing and/or telemetric transmission to anexternal device 954 (e.g., a programmer, local transceiver, or adiagnostic system analyzer). Data acquisition system 950 is controlledby a control signal 956 from the microcontroller 920.

Microcontroller 920 is coupled to a memory 960 by a suitabledata/address bus. The programmable operating parameters used bymicrocontroller 920 are stored in memory 960 and used to customize theoperation of LP 901 to suit the needs of a particular patient. Suchoperating parameters define, for example, pacing pulse amplitude, pulseduration, electrode polarity, rate, sensitivity, automatic features,arrhythmia detection criteria, and the amplitude, waveshape and vectorof each shocking pulse to be delivered to the patient's heart withineach respective tier of therapy.

The operating parameters of LP 901 may be non-invasively programmed intomemory 960 through a telemetry circuit 964 in telemetric communicationvia communication link 966 with external device 954. Telemetry circuit964 allows intracardiac electrograms and status information relating tothe operation of LP 901 (as contained in microcontroller 920 or memory960) to be sent to external device 954 through communication link 966.

LP 901 can further include magnet detection circuitry (not shown),coupled to microcontroller 920, to detect when a magnet is placed overthe unit. A magnet may be used by a clinician to perform various testfunctions of LP 901 and/or to signal microcontroller 920 that externaldevice 954 is in place to receive or transmit data to microcontroller920 through telemetry circuits 964.

LP 901 can further include one or more physiological sensors 970. Suchsensors are commonly referred to as “rate-responsive” sensors becausethey are typically used to adjust pacing stimulation rates according tothe exercise state of the patient. However, physiological sensor 970 mayfurther be used to detect changes in cardiac output, changes in thephysiological condition of the heart, or diurnal changes in activity(e.g., detecting sleep and wake states). Signals generated byphysiological sensors 970 are passed to microcontroller 920 foranalysis. Microcontroller 920 responds by adjusting the various pacingparameters (such as rate, AV Delay, V-V Delay, etc.) at which the atrialand ventricular pacing pulses are administered. While shown as beingincluded within LP 901, physiological sensor(s) 970 may be external toLP 901, yet still be implanted within or carried by the patient.Examples of physiologic sensors might include sensors that, for example,sense respiration rate, pH of blood, ventricular gradient, activity,position/posture, minute ventilation (MV), and so forth.

A battery 972 provides operating power to all of the components in LP901. Battery 972 is capable of operating at low current drains for longperiods of time, and is capable of providing high-current pulses (forcapacitor charging) when the patient requires a shock pulse (e.g., inexcess of 2 A, at voltages above 2 V, for periods of 10 seconds ormore). Battery 972 also desirably has a predictable dischargecharacteristic so that elective replacement time can be detected. As oneexample, LP 901 employs lithium/silver vanadium oxide batteries.

LP 901 further includes an impedance measuring circuit 974, which can beused for many things, including: lead impedance surveillance during theacute and chronic phases for proper lead positioning or dislodgement;detecting operable electrodes and automatically switching to an operablepair if dislodgement occurs; measuring respiration or minuteventilation; measuring thoracic impedance for determining shockthresholds; detecting when the device has been implanted; measuringstroke volume; and detecting the opening of heart valves; and so forth.Impedance measuring circuit 974 is coupled to switch 926 so that anydesired electrode may be used. In this embodiment LP 901 furtherincludes a shocking circuit 980 coupled to microcontroller 920 by adata/address bus 982.

In some embodiments, the LPs 102 and 104 are configured to beimplantable in any chamber of the heart, namely either atrium (RA, LA)or either ventricle (RV, LV). Furthermore, for dual-chamberconfigurations, multiple LPs may be co-implanted (e.g., one in the RAand one in the RV, one in the RV and one in the coronary sinus proximatethe LV). Certain pacemaker parameters and functions depend on (orassume) knowledge of the chamber in which the pacemaker is implanted(and thus with which the LP is interacting; e.g., pacing and/orsensing). Some non-limiting examples include: sensing sensitivity, anevoked response algorithm, use of AF suppression in a local chamber,blanking & refractory periods, etc. Accordingly, each LP needs to knowan identity of the chamber in which the LP is implanted, and processesmay be implemented to automatically identify a local chamber associatedwith each LP.

Processes for chamber identification may also be applied to subcutaneouspacemakers, ICDs, with leads and the like. A device with one or moreimplanted leads, identification and/or confirmation of the chamber intowhich the lead was implanted could be useful in several pertinentscenarios. For example, for a DR or CRT device, automatic identificationand confirmation could mitigate against the possibility of the clinicianinadvertently placing the V lead into the A port of the implantablemedical device, and vice-versa. As another example, for an SR device,automatic identification of implanted chamber could enable the deviceand/or programmer to select and present the proper subset of pacingmodes (e.g., AAI or WI), and for the IPG to utilize the proper set ofsettings and algorithms (e.g., V-AutoCapture vs ACap-Confirm, sensingsensitivities, etc.).

While many of the embodiments of the present technology described abovehave been described as being for use with LP type IMDs, embodiments ofthe present technology that are for use in improving conductivecommunication can also be used with other types of IMDs besides an LP.Accordingly, unless specifically limited to use with an LP, the claimsshould not be limited to use with LP type IMDs. For example, embodimentsof the present technology can also be used with a subcutaneous-ICDand/or a subcutaneous pacemaker, but are not limited thereto.

It is to be understood that the subject matter described herein is notlimited in its application to the details of construction and thearrangement of components set forth in the description herein orillustrated in the drawings hereof. The subject matter described hereinis capable of other embodiments and of being practiced or of beingcarried out in various ways. Also, it is to be understood that thephraseology and terminology used herein is for the purpose ofdescription and should not be regarded as limiting. The use of“including,” “comprising,” or “having” and variations thereof herein ismeant to encompass the items listed thereafter and equivalents thereofas well as additional items. Further, it is noted that the term “basedon” as used herein, unless stated otherwise, should be interpreted asmeaning based at least in part on, meaning there can be one or moreadditional factors upon which a decision or the like is made. Forexample, if a decision is based on the results of a comparison, thatdecision can also be based on one or more other factors in addition tobeing based on results of the comparison.

Embodiments of the present technology have been described above with theaid of functional building blocks illustrating the performance ofspecified functions and relationships thereof. The boundaries of thesefunctional building blocks have often been defined herein for theconvenience of the description. Alternate boundaries can be defined solong as the specified functions and relationships thereof areappropriately performed. Any such alternate boundaries are thus withinthe scope and spirit of the claimed invention. For example, it would bepossible to combine or separate some of the steps shown in FIGS. 8A and8B. For another example, it is possible to change the boundaries of someof the dashed blocks shown in FIGS. 1B and 9.

It is to be understood that the above description is intended to beillustrative, and not restrictive. For example, the above-describedembodiments (and/or aspects thereof) may be used in combination witheach other. In addition, many modifications may be made to adapt aparticular situation or material to the teachings of the embodiments ofthe present technology without departing from its scope. While thedimensions, types of materials and coatings described herein areintended to define the parameters of the embodiments of the presenttechnology, they are by no means limiting and are exemplary embodiments.Many other embodiments will be apparent to those of skill in the artupon reviewing the above description. The scope of the embodiments ofthe present technology should, therefore, be determined with referenceto the appended claims, along with the full scope of equivalents towhich such claims are entitled. In the appended claims, the terms“including” and “in which” are used as the plain-English equivalents ofthe respective terms “comprising” and “wherein.” Moreover, in thefollowing claims, the terms “first,” “second,” and “third,” etc. areused merely as labels, and are not intended to impose numericalrequirements on their objects. Further, the limitations of the followingclaims are not written in means—plus-function format and are notintended to be interpreted based on 35 U.S.C. § 112(f), unless and untilsuch claim limitations expressly use the phrase “means for” followed bya statement of function void of further structure.

What is claimed is:
 1. A method for use with an implantable medicaldevice (IMD) that includes one or more pulse generators and anaccelerometer, the accelerometer configured to selectively produce oneor more accelerometer outputs indicative of an orientation of the IMD,the one or more pulse generators configured to selectively producestimulation pulses and communication pulses, the stimulation pulses foruse in pacing a cardiac chamber or performing neuromodulation, and thecommunication pulses for use in performing conductive communication withanother IMD or a non-implanted device, the method comprising: using theaccelerometer to produce one or more accelerometer outputs indicative ofthe orientation of the IMD; and controlling at least one communicationpulse parameter of one or more communication pulses produced by at leastone of the one or more pulse generators, the controlling based on atleast one of the one or more accelerator outputs indicative of theorientation of the IMD.
 2. The method of claim 1, wherein the at leastone communication pulse parameter, controlled based on at least one ofthe one or more accelerator outputs indicative of the orientation of theIMD, comprises one or more of: communication pulse amplitude;communication pulse width; communication pulse timing; or communicationpulse morphology.
 3. The method of claim 2, wherein: the IMD comprises aleadless pacemaker (LP) configured to be implanted in a cardiac chamber;the one or more accelerometer outputs is/are indicative of theorientation of the LP; the stimulation pulses are for use in pacing thecardiac chamber within which the LP is implanted; and the one or morecommunication pulses are for use in performing conductive communicationwith another LP.
 4. The method of claim 3, wherein the one or moreaccelerometer outputs is/are used to determine at least one of: theorientation of the LP relative to gravity; the orientation of the LPrelative to an orientation of the other LP; or a posture of a patientwithin which the LP is implanted.
 5. The method of claim 3, wherein: thecontrolling the at least one communication pulse parameter, based on atleast one of the one or more accelerator outputs indicative of theorientation of the LP, comprises controlling the communication pulsetiming so that one or more communication pulses having a specifiedcommunication pulse amplitude is/are temporally produced so that a senseamplitude of one or more communication pulses received by the other LPwill exceed a sense threshold.
 6. The method of claim 5, wherein: thecontrolling the at least one communication pulse parameter, based on atleast one of the one or more accelerator outputs indicative of theorientation of the LP, also comprises controlling the communicationpulse timing so that one or more communication pulses is/are temporallyproduced during a refractory period of the cardiac chamber within whichthe LP is implanted.
 7. The method of claim 3, wherein: the controllingthe at least one communication pulse parameter, based on at least one ofthe one or more accelerator outputs indicative of the orientation of theLP, comprises controlling at least one of the communication pulseamplitude or the communication pulse width so that a sense amplitude ofone or more communication pulses received by the other LP will exceed asense threshold.
 8. The method of claim 7, wherein: the controlling theat least one communication pulse parameter, based on at least one of theone or more accelerator outputs indicative of the orientation of the LP,comprises increasing at least one of the communication pulse amplitudeor the communication pulse width in response to predicting that withoutthe increasing one or more communication pulses received by the other LPwill be below a sense threshold.
 9. The method of claim 7, wherein: thecontrolling the at least one communication pulse parameter, based on atleast one of the one or more accelerator outputs indicative of theorientation of the LP, comprises reducing at least one of thecommunication pulse amplitude or the communication pulse width inresponse to predicting that even with the reducing communication pulsesreceived by the other LP will exceed a sense threshold.
 10. The methodof claim 3, wherein: each of the LPs include a plurality of electrodesthat can be used for transmitting and receiving communication pulses;and further comprising one of the LPs controlling, based on at least oneof the one or more accelerator outputs indicative of the orientation ofthe one of the LPs, which electrodes, of the plurality of electrodes ofone of the LPs, are used to transmit or receive communication pulses toor from the other one of the LPs.
 11. An implantable medical device(IMD), comprising: one or more pulse generators configured toselectively produce stimulation pulses and communication pulses, thestimulation pulses for use in pacing a cardiac chamber or performingneuromodulation, and the communication pulses for use in performingconductive communication with another IMD or a non-implanted device; anaccelerometer configured to selectively produce one or moreaccelerometer outputs indicative of an orientation of the IMD; and acontroller communicatively coupled to the accelerometer and to the oneor more pulse generators; the controller configured to control at leastone communication pulse parameter of one or more communication pulsesproduced by at least one of the one or more pulse generators, based onat least one of the one or more accelerator outputs indicative of theorientation of the IMD.
 12. The IMD of claim 11, wherein the at leastone communication pulse parameter, that the controller controls based onat least one of the one or more accelerator outputs indicative of theorientation of the IMD, comprises one or more of: communication pulseamplitude; communication pulse width; communication pulse timing; orcommunication pulse morphology.
 13. The IMD of claim 12, wherein: theIMD comprises a leadless pacemaker (LP) configured to be implanted in acardiac chamber; the one or more accelerometer outputs is/are indicativeof the orientation of the LP; the stimulation pulses are for use inpacing the cardiac chamber within which the LP is implanted; and thecommunication pulses are for use in performing conductive communicationwith another LP.
 14. The IMD of claim 13, wherein the one or moreaccelerometer outputs is/are used by the controller to determine atleast one of: the orientation of the LP relative to gravity; theorientation of the LP relative to an orientation of the other LP; or aposture of a patient within which the LP is implanted.
 15. The IMD ofclaim 13, wherein: the controller is configured to control, based on atleast one of the one or more accelerator outputs indicative of theorientation of the LP, the communication pulse timing so that one ormore communication pulses having a specified communication pulseamplitude is/are temporally produced so that a sense amplitude of one ormore communication pulses received by the other LP will exceed a sensethreshold.
 16. The IMD of claim 15, wherein: the controller is alsoconfigured to control, based on at least one of the one or moreaccelerator outputs indicative of the orientation of the LP, thecommunication pulse timing so that one or more communication pulsesis/are temporally produced during a refractory period of the cardiacchamber within which the LP is implanted.
 17. The IMD of claim 13,wherein: the controller is configured to control, based on at least oneof the one or more accelerator outputs indicative of the orientation ofthe LP, at least one of the communication pulse amplitude or thecommunication pulse width so that a sense amplitude of one or morecommunication pulses received by the other LP will exceed a sensethreshold.
 18. The IMD of claim 17, wherein: the controller isconfigured to increase at least one of the communication pulse amplitudeor the communication pulse width in response to predicting, based on atleast one of the one or more accelerator outputs indicative of theorientation of the LP, that without the increasing a sense amplitude ofone or more communication pulses received by the other LP will be belowa sense threshold.
 19. The IMD of claim 17, wherein: the controller isconfigured to reduce at least one of the communication pulse amplitudeor the communication pulse width in response to predicting, based on atleast one of the one or more accelerator outputs indicative of theorientation of the LP, that even with the reducing a sense amplitude ofone or more communication pulses received by the other LP will exceed asense threshold.
 20. The IMD of claim 13, wherein: the LP include aplurality of electrodes that can be used for transmitting and receivingcommunication pulses; and the controller is configured to control, basedon at least one of the one or more accelerator outputs indicative of theorientation of the LPs, which electrodes, of the plurality of electrodesof the LP, are used to transmit or receive communication pulses to orfrom the other LP.
 21. An implantable system, comprising: a firstleadless pacemaker (LP) implanted within an atrial chamber; a second LPimplanted within a ventricular chamber; each of the first and second LPsincluding one or more pulse generators configured to selectively producestimulation pulses and communication pulses, the stimulation pulses foruse in pacing the cardiac chamber within which the LP is implanted, thecommunication pulses for use in performing conductive communication withthe other LP; the first LP including an accelerometer configured toselectively produce one or more accelerometer outputs indicative of anorientation of the first LP; the first LP also including a controllercommunicatively coupled to the accelerometer and to the one or morepulse generators of the first LP; and the controller of the first LPconfigured to control at least one communication pulse parameter of oneor more communication pulses produced by at least one of the one or morepulse generators of the first LP, based on at least one of the one ormore accelerator outputs indicative of the orientation of the first LP.22. The system of claim 21, wherein: the second LP includes anaccelerometer configured to selectively produce one or moreaccelerometer outputs indicative of an orientation of the second LP; thesecond LP also includes a controller communicatively coupled to theaccelerometer and to the one or more pulse generators of the second LP;and the controller of the second LP configured to control at least onecommunication pulse parameter of one or more communication pulsesproduced by at least one of the one or more pulse generators of thesecond LP, based on at least one of the one or more accelerator outputsindicative of the orientation of the second LP.